Replies to post #96468 on Biotech Values

[DewDiligence]

Idenix isn't for sale plus Novartis holds half…

Not anymore. NVS’ equity stake, fully diluted, is down to 40% (#msg-49997072), so IDIX could conceivably be acquired by someone else.